Does BELIMUMAB Cause Mobility decreased? 110 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Mobility decreased have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.4% of all adverse event reports for BELIMUMAB.
110
Reports of Mobility decreased with BELIMUMAB
0.4%
of all BELIMUMAB reports
2
Deaths
30
Hospitalizations
How Dangerous Is Mobility decreased From BELIMUMAB?
Of the 110 reports, 2 (1.8%) resulted in death, 30 (27.3%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which BELIMUMAB Alternatives Have Lower Mobility decreased Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID